Mirza v. Orange Regional Medical Center

CourtDistrict Court, S.D. New York
DecidedMarch 16, 2021
Docket7:20-cv-00556
StatusUnknown

This text of Mirza v. Orange Regional Medical Center (Mirza v. Orange Regional Medical Center) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mirza v. Orange Regional Medical Center, (S.D.N.Y. 2021).

Opinion

The Court shall hold a pre-motion conference to address Plaintiff's anticipated motion to vacate the Stipulation "So Ordered" by Judge Castel on April 27, 2020 (Doc. 33). The conference shall be held by telephone on April 20, 2021 at 10:00 a.m. At the time of the scheduled March 09, 2021 conference, all parties shall call the following number: (888) 398-2342; access code: 3456831. The Clerk of the Court is respectfully directed to terminate the motion sequence pending at Doc. 79. SO ORD D.

et al, Case #: 7:20-cv-00556 (PMH). Philip M. Halpern mn To Vacate Stipulation For The Protection And United States District Judge uments. Dated: White Plains, New York March 16, 2021 Pursuant to Rule 2.C of Your Honor’s Individual Practices for Civil Cases, I write as the Plaintiff to respectfully submit this request, for permission to file a Motion to Vacate the “Stipulation For The Protection and Exchange of Confidential Information and Documents”(“‘Stipulation”) ECF No 33,(see Ex. A). I respectfully request Your Honor to waive the pre-motion conference as I am Pro Se. As represented in accompanying certification, (see Ex. B), I have met and conferred in a good faith attempt to resolve the parties’ disputes but the issues remain unresolved,(see Ex.C-K). I. Stipulation Issues and Implications: A. Plaintiff Was Induced to Enter Into The Stipulation: Defendants crafted this excessively broad blanket protective order (“BPO”) in its entirety for their benefit, which functions like an Umbrella Protective Order. As emails between Plaintiffs former counsel Cole Schotz and counsel for Defendants evidence, there was no real negotiation and the Stipulation that was drafted in its entirety by defendants/Jackson Lewis was accepted by Cole Schotz without making virtually any changes, and then I was induced, mislead and misrepresented into entering it, by the law firm representing me by presenting the Stipulation as; “extremely standard and boilerplate,”

and required for my case by the Court. I have since learned that the Stipulation is not standard at all but custom created in violation of FRCP Rule 26 (c), a voluntary agreement, and not required by the Court for my case. There are no trade secrets, confidential research, development or commercial information, in this lawsuit for either party. I anticipate that defendants will claim that the Stipulation is necessary to protect business, personal or confidential patient information,

but that is not the case. Patient confidentiality requirements are met by redaction FRCP 5.2, pursuant to the S.D.N.Y. Electronic Case Filling Rules & Instructions, as I have done in my production and do not require a Stipulation. B. Stipulation Violates FRCP Rule 26 (c): There are multiple problematic aspects of the Stipulation including paragraphs: 1, 2, 3, 5, 6, 7, 8, 9, 11, and 15. Paragraph 1 gives defendants the ability to “..designate as Confidential Matter any information”, which then prevents Plaintiff from public filing and sharing, rights protected by FRCP 1 and 1st Amendment. See id. ¶¶2, 5 -7, and 15. It also prevents Plaintiff from using confidential documents or deposition testimony in multiple other lawsuits currently pending against defendants or sharing documents with plaintiffs

in those actions, see id. ¶2. Challenging designations is burdensome with a 14-day wait, and provides only the designating party to take the dispute to the Court, with no time line, see id ¶8. It also prevents public filing of documents by Plaintiff in motions and a 14 day wait prior to filing which is burdensome in the absence of good cause and overdesignation abuse, see id. ¶9. C. Overdesignation And Over Categorization, And Abuse by Defendants: The inappropriate nature of this Stipulation has already become clear, as Defendants have used the confidentiality claim like a rubber stamp and have declared every document produced (see Ex. L) as confidential none of which are documents that can be declared as confidential per Rule 26(c). Many are publicly available documents that are online on defendant's website-policy & procedure manuals others widely disseminated, in addition to publicly filed exhibits attached with the amended complaint, which are clearly not trade secrets or other documents warranting confidentiality. II. LEGAL STANDARD: Current Lawsuit Does Not Warrant a Stipulation A. Stipulation Violates FRCP Rule 26 (c), FRCP Rule 1, FRCP 5(d) and Local Rule SDNY 5.1: “The court may, for good cause, issue an order to protect a party or person from annoyance,

embarrassment, oppression, or undue burden or expense, including one or more of the following: (G) requiring that a trade secret or other confidential research, development, or commercial information not be revealed or be revealed only in a specified way;” FRCP 26(c)(1)(G). “In order to show that certain designated information should be protected under Rule 26(c) this court requires the party seeking such a protective order to show:(1) that the information rises to the level of a trade secret, and (2) that there is good cause to protect the information, Fed. R. Civ. P. 26(c).” See Turick ex rel. Turick v Yamaha Motor Corp., 121 FRD 32, 35 [S.D.N.Y. 1988]. B. Stipulation Violates FRCP Rule 26(c): Permitting the parties in a case "to adjudicate their own case based upon their own self-interest" by designating anything they wish to keep secret as

Confidential Information violates both the spirit and the letter of Rule 26(c). See Procter & Gamble Co. v. Bankers Trust Co., 78 F.3d 219, 227 (6th Cir. 1996) (requiring vacature of protective order which "allows the parties to control public access to court papers"). Yet, such a result is exactly what defendants have sought here. The Stipulation also violates FRCP Rules 1 and 5(d) in addition to FRCP Rule 26(c) all of which counsel in favor of the statutory right of access to discovery materials in the Second Circuit. C. Defendants Cannot Establish “Good Cause”: “A protective order granted on the basis of a stipulation by the parties carries less weight than a protective order granted after a hearing to show good cause”. See In re (EPDM) Antitrust Litigation, 255 F.R.D. 308, 321 (D. Conn. 2009). "Stipulation contains no statement or demonstration of "good cause" whatsoever by defendants therefore it does not meet the standard and has to be vacated, as the Federal Rules require proper showing of good cause by the party seeking protection. BPO is not permitted under Rule 26(c). “A blanket order in the absence of any specific showing of privilege, trade secret material, or the like is not authorized by the rules.” See United States v. Hooker Chemicals & Plastics Corp., 90

F.R.D. 421,424 (W.D.N.Y.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Seattle Times Co. v. Rhinehart
467 U.S. 20 (Supreme Court, 1984)
Public Citizen v. Liggett Group, Inc.
858 F.2d 775 (First Circuit, 1988)
Lugosch v. Pyramid Co. of Onondaga
435 F.3d 110 (Second Circuit, 2006)
Fournier v. Erickson
242 F. Supp. 2d 318 (S.D. New York, 2003)
United States v. Hooker Chemicals & Plastics Corp.
90 F.R.D. 421 (W.D. New York, 1981)

Cite This Page — Counsel Stack

Bluebook (online)
Mirza v. Orange Regional Medical Center, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mirza-v-orange-regional-medical-center-nysd-2021.